Last reviewed · How we verify

PROBENECID

FDA-approved approved Small molecule Quality 5/100

PROBENECID is a drug. It is currently FDA-approved (first approved 1951).

At a glance

Generic namePROBENECID
ModalitySmall molecule
PhaseFDA-approved
First approval1951

Approved indications

No approved indications tracked.

Common side effects

Serious adverse events

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
FDA labelMechanism, indications, dosing, boxed warnings, drug interactions
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about PROBENECID

What is PROBENECID?

PROBENECID is a Small molecule drug.

When was PROBENECID approved?

PROBENECID was first approved on 1951.

What development phase is PROBENECID in?

PROBENECID is FDA-approved (marketed).

What are the side effects of PROBENECID?

Common side effects of PROBENECID include Diarrhea, Nausea, Vulvovaginal mycotic infection, Headache, Vomiting. Serious adverse events: Serious adverse reactions (unspecified).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing